nodes	percent_of_prediction	percent_of_DWPC	metapath
Cycloserine—DDC—Catecholamine biosynthesis—TH—peripheral nervous system neoplasm	0.0777	0.215	CbGpPWpGaD
Cycloserine—DDC—Parkinsons Disease Pathway—PINK1—peripheral nervous system neoplasm	0.0642	0.178	CbGpPWpGaD
Cycloserine—Neurological symptom—Tretinoin—peripheral nervous system neoplasm	0.0369	0.0578	CcSEcCtD
Cycloserine—Neurological symptom—Isotretinoin—peripheral nervous system neoplasm	0.0369	0.0578	CcSEcCtD
Cycloserine—Paresis—Topotecan—peripheral nervous system neoplasm	0.0308	0.0482	CcSEcCtD
Cycloserine—DDC—Dopamine metabolism—TH—peripheral nervous system neoplasm	0.0303	0.0839	CbGpPWpGaD
Cycloserine—Neurological symptom—Alitretinoin—peripheral nervous system neoplasm	0.028	0.0438	CcSEcCtD
Cycloserine—DDC—Biogenic Amine Synthesis—TH—peripheral nervous system neoplasm	0.027	0.0748	CbGpPWpGaD
Cycloserine—DDC—Amine-derived hormones—TH—peripheral nervous system neoplasm	0.0256	0.0711	CbGpPWpGaD
Cycloserine—Neurological symptom—Cisplatin—peripheral nervous system neoplasm	0.0238	0.0373	CcSEcCtD
Cycloserine—Paresis—Vincristine—peripheral nervous system neoplasm	0.0223	0.0349	CcSEcCtD
Cycloserine—DDC—Nicotine Activity on Dopaminergic Neurons—TH—peripheral nervous system neoplasm	0.0206	0.0572	CbGpPWpGaD
Cycloserine—DDC—SIDS Susceptibility Pathways—PHOX2B—peripheral nervous system neoplasm	0.0157	0.0436	CbGpPWpGaD
Cycloserine—DDC—Dopaminergic Neurogenesis—TH—peripheral nervous system neoplasm	0.0155	0.043	CbGpPWpGaD
Cycloserine—DDC—Parkinsons Disease Pathway—TH—peripheral nervous system neoplasm	0.0128	0.0356	CbGpPWpGaD
Cycloserine—Aggression—Isotretinoin—peripheral nervous system neoplasm	0.0127	0.0199	CcSEcCtD
Cycloserine—Aggression—Tretinoin—peripheral nervous system neoplasm	0.0127	0.0199	CcSEcCtD
Cycloserine—Dysarthria—Tretinoin—peripheral nervous system neoplasm	0.0118	0.0184	CcSEcCtD
Cycloserine—Dysarthria—Isotretinoin—peripheral nervous system neoplasm	0.0118	0.0184	CcSEcCtD
Cycloserine—Coma—Tretinoin—peripheral nervous system neoplasm	0.0102	0.0159	CcSEcCtD
Cycloserine—Coma—Isotretinoin—peripheral nervous system neoplasm	0.0102	0.0159	CcSEcCtD
Cycloserine—Aggression—Alitretinoin—peripheral nervous system neoplasm	0.00962	0.0151	CcSEcCtD
Cycloserine—Drug hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.00918	0.0144	CcSEcCtD
Cycloserine—Dysarthria—Alitretinoin—peripheral nervous system neoplasm	0.00894	0.014	CcSEcCtD
Cycloserine—Cardiac failure congestive—Tretinoin—peripheral nervous system neoplasm	0.00893	0.014	CcSEcCtD
Cycloserine—Cardiac failure congestive—Isotretinoin—peripheral nervous system neoplasm	0.00893	0.014	CcSEcCtD
Cycloserine—SLC36A2—SLC-mediated transmembrane transport—SLC2A1—peripheral nervous system neoplasm	0.00875	0.0243	CbGpPWpGaD
Cycloserine—Drug hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.0085	0.0133	CcSEcCtD
Cycloserine—SLC36A2—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	0.00841	0.0233	CbGpPWpGaD
Cycloserine—Osteoarthritis—Tretinoin—peripheral nervous system neoplasm	0.0081	0.0127	CcSEcCtD
Cycloserine—Osteoarthritis—Isotretinoin—peripheral nervous system neoplasm	0.0081	0.0127	CcSEcCtD
Cycloserine—Psychotic disorder—Tretinoin—peripheral nervous system neoplasm	0.00791	0.0124	CcSEcCtD
Cycloserine—Psychotic disorder—Isotretinoin—peripheral nervous system neoplasm	0.00791	0.0124	CcSEcCtD
Cycloserine—Coma—Alitretinoin—peripheral nervous system neoplasm	0.00772	0.0121	CcSEcCtD
Cycloserine—Dysarthria—Cisplatin—peripheral nervous system neoplasm	0.00761	0.0119	CcSEcCtD
Cycloserine—Coma—Vincristine—peripheral nervous system neoplasm	0.00744	0.0116	CcSEcCtD
Cycloserine—Cardiac failure congestive—Alitretinoin—peripheral nervous system neoplasm	0.00677	0.0106	CcSEcCtD
Cycloserine—Drowsiness—Tretinoin—peripheral nervous system neoplasm	0.00624	0.00976	CcSEcCtD
Cycloserine—Drowsiness—Isotretinoin—peripheral nervous system neoplasm	0.00624	0.00976	CcSEcCtD
Cycloserine—Osteoarthritis—Alitretinoin—peripheral nervous system neoplasm	0.00614	0.0096	CcSEcCtD
Cycloserine—Psychotic disorder—Alitretinoin—peripheral nervous system neoplasm	0.00599	0.00938	CcSEcCtD
Cycloserine—Cardiac failure congestive—Cisplatin—peripheral nervous system neoplasm	0.00576	0.00902	CcSEcCtD
Cycloserine—Cardiac failure congestive—Etoposide—peripheral nervous system neoplasm	0.00528	0.00826	CcSEcCtD
Cycloserine—DDC—Parkinsons Disease Pathway—CASP3—peripheral nervous system neoplasm	0.00522	0.0145	CbGpPWpGaD
Cycloserine—Drowsiness—Alitretinoin—peripheral nervous system neoplasm	0.00473	0.0074	CcSEcCtD
Cycloserine—Tremor—Tretinoin—peripheral nervous system neoplasm	0.00457	0.00715	CcSEcCtD
Cycloserine—Tremor—Isotretinoin—peripheral nervous system neoplasm	0.00457	0.00715	CcSEcCtD
Cycloserine—DDC—SIDS Susceptibility Pathways—NTRK2—peripheral nervous system neoplasm	0.00453	0.0125	CbGpPWpGaD
Cycloserine—SLC36A2—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	0.00445	0.0123	CbGpPWpGaD
Cycloserine—Convulsion—Isotretinoin—peripheral nervous system neoplasm	0.00422	0.00661	CcSEcCtD
Cycloserine—Convulsion—Tretinoin—peripheral nervous system neoplasm	0.00422	0.00661	CcSEcCtD
Cycloserine—Convulsion—Melphalan—peripheral nervous system neoplasm	0.00417	0.00652	CcSEcCtD
Cycloserine—DDC—SIDS Susceptibility Pathways—TH—peripheral nervous system neoplasm	0.00415	0.0115	CbGpPWpGaD
Cycloserine—Confusional state—Tretinoin—peripheral nervous system neoplasm	0.00401	0.00628	CcSEcCtD
Cycloserine—Confusional state—Isotretinoin—peripheral nervous system neoplasm	0.00401	0.00628	CcSEcCtD
Cycloserine—Dysarthria—Epirubicin—peripheral nervous system neoplasm	0.00391	0.00612	CcSEcCtD
Cycloserine—Dysarthria—Doxorubicin—peripheral nervous system neoplasm	0.00362	0.00566	CcSEcCtD
Cycloserine—Paraesthesia—Topotecan—peripheral nervous system neoplasm	0.0036	0.00564	CcSEcCtD
Cycloserine—SLC36A2—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	0.00358	0.00992	CbGpPWpGaD
Cycloserine—Paraesthesia—Tretinoin—peripheral nervous system neoplasm	0.00357	0.00559	CcSEcCtD
Cycloserine—Paraesthesia—Isotretinoin—peripheral nervous system neoplasm	0.00357	0.00559	CcSEcCtD
Cycloserine—DDC—Amino acid and derivative metabolism—TH—peripheral nervous system neoplasm	0.00357	0.0099	CbGpPWpGaD
Cycloserine—Somnolence—Isotretinoin—peripheral nervous system neoplasm	0.00354	0.00553	CcSEcCtD
Cycloserine—Somnolence—Tretinoin—peripheral nervous system neoplasm	0.00354	0.00553	CcSEcCtD
Cycloserine—Paraesthesia—Melphalan—peripheral nervous system neoplasm	0.00353	0.00552	CcSEcCtD
Cycloserine—SLC36A2—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	0.00351	0.00973	CbGpPWpGaD
Cycloserine—Tremor—Alitretinoin—peripheral nervous system neoplasm	0.00346	0.00542	CcSEcCtD
Cycloserine—DDC—Circadian rythm related genes—TH—peripheral nervous system neoplasm	0.00339	0.00939	CbGpPWpGaD
Cycloserine—Coma—Epirubicin—peripheral nervous system neoplasm	0.00338	0.00529	CcSEcCtD
Cycloserine—DDC—SIDS Susceptibility Pathways—BDNF—peripheral nervous system neoplasm	0.00338	0.00936	CbGpPWpGaD
Cycloserine—Feeling abnormal—Topotecan—peripheral nervous system neoplasm	0.00331	0.00517	CcSEcCtD
Cycloserine—Feeling abnormal—Tretinoin—peripheral nervous system neoplasm	0.00328	0.00513	CcSEcCtD
Cycloserine—Feeling abnormal—Isotretinoin—peripheral nervous system neoplasm	0.00328	0.00513	CcSEcCtD
Cycloserine—Convulsion—Alitretinoin—peripheral nervous system neoplasm	0.0032	0.00501	CcSEcCtD
Cycloserine—Vertigo—Vincristine—peripheral nervous system neoplasm	0.0032	0.00501	CcSEcCtD
Cycloserine—Coma—Doxorubicin—peripheral nervous system neoplasm	0.00313	0.00489	CcSEcCtD
Cycloserine—Convulsion—Vincristine—peripheral nervous system neoplasm	0.00309	0.00483	CcSEcCtD
Cycloserine—Confusional state—Alitretinoin—peripheral nervous system neoplasm	0.00304	0.00476	CcSEcCtD
Cycloserine—DDC—Circadian rythm related genes—NTRK1—peripheral nervous system neoplasm	0.00301	0.00835	CbGpPWpGaD
Cycloserine—Cardiac failure congestive—Epirubicin—peripheral nervous system neoplasm	0.00296	0.00463	CcSEcCtD
Cycloserine—Hypersensitivity—Topotecan—peripheral nervous system neoplasm	0.00296	0.00462	CcSEcCtD
Cycloserine—Tremor—Cisplatin—peripheral nervous system neoplasm	0.00295	0.00462	CcSEcCtD
Cycloserine—Hypersensitivity—Isotretinoin—peripheral nervous system neoplasm	0.00293	0.00459	CcSEcCtD
Cycloserine—Hypersensitivity—Tretinoin—peripheral nervous system neoplasm	0.00293	0.00459	CcSEcCtD
Cycloserine—Hypersensitivity—Melphalan—peripheral nervous system neoplasm	0.00289	0.00453	CcSEcCtD
Cycloserine—DDC—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.00279	0.00774	CbGpPWpGaD
Cycloserine—Cardiac failure congestive—Doxorubicin—peripheral nervous system neoplasm	0.00274	0.00429	CcSEcCtD
Cycloserine—Convulsion—Cisplatin—peripheral nervous system neoplasm	0.00273	0.00427	CcSEcCtD
Cycloserine—Paraesthesia—Alitretinoin—peripheral nervous system neoplasm	0.00271	0.00424	CcSEcCtD
Cycloserine—Osteoarthritis—Epirubicin—peripheral nervous system neoplasm	0.00268	0.0042	CcSEcCtD
Cycloserine—Somnolence—Alitretinoin—peripheral nervous system neoplasm	0.00268	0.00419	CcSEcCtD
Cycloserine—Feeling abnormal—Dactinomycin—peripheral nervous system neoplasm	0.00268	0.00419	CcSEcCtD
Cycloserine—Paraesthesia—Vincristine—peripheral nervous system neoplasm	0.00261	0.00408	CcSEcCtD
Cycloserine—Vertigo—Etoposide—peripheral nervous system neoplasm	0.00259	0.00405	CcSEcCtD
Cycloserine—Rash—Topotecan—peripheral nervous system neoplasm	0.00253	0.00396	CcSEcCtD
Cycloserine—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.00253	0.00395	CcSEcCtD
Cycloserine—Headache—Topotecan—peripheral nervous system neoplasm	0.00251	0.00393	CcSEcCtD
Cycloserine—Rash—Tretinoin—peripheral nervous system neoplasm	0.00251	0.00393	CcSEcCtD
Cycloserine—Rash—Isotretinoin—peripheral nervous system neoplasm	0.00251	0.00393	CcSEcCtD
Cycloserine—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.00251	0.00392	CcSEcCtD
Cycloserine—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.00251	0.00392	CcSEcCtD
Cycloserine—Convulsion—Etoposide—peripheral nervous system neoplasm	0.0025	0.00391	CcSEcCtD
Cycloserine—Headache—Tretinoin—peripheral nervous system neoplasm	0.00249	0.0039	CcSEcCtD
Cycloserine—Headache—Isotretinoin—peripheral nervous system neoplasm	0.00249	0.0039	CcSEcCtD
Cycloserine—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.00249	0.00389	CcSEcCtD
Cycloserine—Osteoarthritis—Doxorubicin—peripheral nervous system neoplasm	0.00248	0.00389	CcSEcCtD
Cycloserine—Rash—Melphalan—peripheral nervous system neoplasm	0.00248	0.00387	CcSEcCtD
Cycloserine—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.00247	0.00387	CcSEcCtD
Cycloserine—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.0024	0.00375	CcSEcCtD
Cycloserine—Confusional state—Etoposide—peripheral nervous system neoplasm	0.00237	0.00371	CcSEcCtD
Cycloserine—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.00231	0.00361	CcSEcCtD
Cycloserine—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.00222	0.00348	CcSEcCtD
Cycloserine—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.00214	0.00335	CcSEcCtD
Cycloserine—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.00212	0.00331	CcSEcCtD
Cycloserine—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.00211	0.00331	CcSEcCtD
Cycloserine—Somnolence—Etoposide—peripheral nervous system neoplasm	0.00209	0.00327	CcSEcCtD
Cycloserine—Drowsiness—Epirubicin—peripheral nervous system neoplasm	0.00207	0.00324	CcSEcCtD
Cycloserine—Rash—Dactinomycin—peripheral nervous system neoplasm	0.00205	0.00321	CcSEcCtD
Cycloserine—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.00194	0.00303	CcSEcCtD
Cycloserine—Drowsiness—Doxorubicin—peripheral nervous system neoplasm	0.00191	0.003	CcSEcCtD
Cycloserine—Rash—Alitretinoin—peripheral nervous system neoplasm	0.0019	0.00297	CcSEcCtD
Cycloserine—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.0019	0.00297	CcSEcCtD
Cycloserine—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.00189	0.00296	CcSEcCtD
Cycloserine—Headache—Alitretinoin—peripheral nervous system neoplasm	0.00189	0.00296	CcSEcCtD
Cycloserine—DDC—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.00189	0.00523	CbGpPWpGaD
Cycloserine—Rash—Vincristine—peripheral nervous system neoplasm	0.00183	0.00287	CcSEcCtD
Cycloserine—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.00183	0.00286	CcSEcCtD
Cycloserine—Headache—Vincristine—peripheral nervous system neoplasm	0.00182	0.00285	CcSEcCtD
Cycloserine—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.00173	0.00271	CcSEcCtD
Cycloserine—DDC—SIDS Susceptibility Pathways—CASP3—peripheral nervous system neoplasm	0.00169	0.00468	CbGpPWpGaD
Cycloserine—Rash—Cisplatin—peripheral nervous system neoplasm	0.00162	0.00253	CcSEcCtD
Cycloserine—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.00162	0.00253	CcSEcCtD
Cycloserine—Rash—Etoposide—peripheral nervous system neoplasm	0.00148	0.00232	CcSEcCtD
Cycloserine—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.00148	0.00232	CcSEcCtD
Cycloserine—Headache—Etoposide—peripheral nervous system neoplasm	0.00147	0.00231	CcSEcCtD
Cycloserine—Vertigo—Epirubicin—peripheral nervous system neoplasm	0.00145	0.00227	CcSEcCtD
Cycloserine—Convulsion—Epirubicin—peripheral nervous system neoplasm	0.0014	0.00219	CcSEcCtD
Cycloserine—DDC—Metabolism—GNS—peripheral nervous system neoplasm	0.00136	0.00378	CbGpPWpGaD
Cycloserine—Vertigo—Doxorubicin—peripheral nervous system neoplasm	0.00134	0.0021	CcSEcCtD
Cycloserine—Confusional state—Epirubicin—peripheral nervous system neoplasm	0.00133	0.00208	CcSEcCtD
Cycloserine—DDC—Metabolism—NME1—peripheral nervous system neoplasm	0.00131	0.00362	CbGpPWpGaD
Cycloserine—Convulsion—Doxorubicin—peripheral nervous system neoplasm	0.0013	0.00203	CcSEcCtD
Cycloserine—DDC—Metabolism—COX2—peripheral nervous system neoplasm	0.00126	0.00349	CbGpPWpGaD
Cycloserine—Confusional state—Doxorubicin—peripheral nervous system neoplasm	0.00123	0.00193	CcSEcCtD
Cycloserine—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	0.00118	0.00185	CcSEcCtD
Cycloserine—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.00117	0.00184	CcSEcCtD
Cycloserine—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	0.0011	0.00172	CcSEcCtD
Cycloserine—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.00109	0.0017	CcSEcCtD
Cycloserine—Somnolence—Doxorubicin—peripheral nervous system neoplasm	0.00109	0.0017	CcSEcCtD
Cycloserine—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.00101	0.00157	CcSEcCtD
Cycloserine—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.000972	0.00152	CcSEcCtD
Cycloserine—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.0009	0.00141	CcSEcCtD
Cycloserine—DDC—Circadian rythm related genes—TP53—peripheral nervous system neoplasm	0.000884	0.00245	CbGpPWpGaD
Cycloserine—Rash—Epirubicin—peripheral nervous system neoplasm	0.000832	0.0013	CcSEcCtD
Cycloserine—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000831	0.0013	CcSEcCtD
Cycloserine—Headache—Epirubicin—peripheral nervous system neoplasm	0.000827	0.00129	CcSEcCtD
Cycloserine—DDC—Metabolism—ENO2—peripheral nervous system neoplasm	0.000826	0.00229	CbGpPWpGaD
Cycloserine—Rash—Doxorubicin—peripheral nervous system neoplasm	0.00077	0.0012	CcSEcCtD
Cycloserine—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000769	0.0012	CcSEcCtD
Cycloserine—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000765	0.0012	CcSEcCtD
Cycloserine—DDC—Metabolism—BCHE—peripheral nervous system neoplasm	0.000698	0.00193	CbGpPWpGaD
Cycloserine—DDC—Metabolism—SLC2A1—peripheral nervous system neoplasm	0.000666	0.00184	CbGpPWpGaD
Cycloserine—DDC—Metabolism—TH—peripheral nervous system neoplasm	0.000656	0.00182	CbGpPWpGaD
Cycloserine—DDC—Metabolism—GNAS—peripheral nervous system neoplasm	0.000536	0.00148	CbGpPWpGaD
Cycloserine—DDC—Metabolism—ABCB1—peripheral nervous system neoplasm	0.000526	0.00146	CbGpPWpGaD
Cycloserine—DDC—Metabolism—AKT1—peripheral nervous system neoplasm	0.000145	0.000401	CbGpPWpGaD
